Limitations of Presently AvailableIn VitroRelease Data for the Prediction ofIn VivoPerformance
Authors:
- 1 January 1991
- journal article
- research article
- Published by Taylor & Francis in Drug Development and Industrial Pharmacy
- Vol. 17 (9) , 1157-1176
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Preliminary Evaluation of the Correlation Between in Vitro Release and in Vivo Bioavailability of Two Aminophylline Slow-Release TabletsJournal of Pharmaceutical Sciences, 1990
- A Flow-Through Dissolution Approach to In Vivo/In Vitro Correlation of Adinazolam Release from Sustained Release FormulationsDrug Development and Industrial Pharmacy, 1989
- Further Considerations in Correlating in Vitro - In Vivo Data Employing Mean-Time Concept Based on Statistical MomentsDrug Development and Industrial Pharmacy, 1988
- In Vitro Topographical Characterization as a Predictor of in Vivo Controlled Release Quinidine Gluconate BioavailabilityDrug Development and Industrial Pharmacy, 1986
- In vitro and in vivo deconvolution assessment of drug release kinetics from oxprenolol Oros preparations.British Journal of Clinical Pharmacology, 1985
- Pharmacokinetic investigation of the absorption of oxprenolol from Oros delivery systems in healthy volunteers: comparison of in vivo and in vitro drug release.British Journal of Clinical Pharmacology, 1985
- In Vitro–in Vivo Correlation and Dissolution Studies with Oral Theophylline Dosage FormsJournal of Pharmaceutical Sciences, 1985
- Comparison of two dissolution apparatuses with correlation ofin vitro-in vivo data for prednisone and prednisolone tabletsBiopharmaceutics & Drug Disposition, 1979
- Predictive Conversion of In Vitro Drug Dissolution Data into In Vivo Drug Response versus Time Profiles Exemplified for Plasma Levels of WarfarinJournal of Pharmaceutical Sciences, 1977
- Simple transformation method for predicting plasma drug profiles from dissolution ratesJournal of Pharmaceutical Sciences, 1976